You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 4, April 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology, Other
 •Alert me on articles by topic

Axillary Fox-Fordyce Disease Treated With Liposuction-Assisted Curettage

K. Mireille Chae, MD; Michael A. Marschall, MD; Stephanie F. Marschall, MD
From the Department of Dermatology, Rush-Presbyterian-St Luke's Medical Center (Drs Chae and Stephanie F. Marschall), and the Division of Plastic Surgery, University of Illinois at Chicago (Dr Michael A. Marschall), Chicago, Ill.

Arch Dermatol. 2002;138:452-454.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF A CASE

A 33-year-old African American woman presented with a long history of extremely pruritic, burning lesions in the axillae, on the breasts, and in the inguinal area. The eruption first began at age 15 years, with flares following pregnancy.

On physical examination, the patient was noted to have numerous discrete, skin-colored papules in the axillae, around the areolae, and in the inguinal area (Figure 1). Biopsy results of one of these lesions were consistent with a diagnosis of Fox-Fordyce disease or apocrine miliaria.


 
Figure appears in full text version.
Figure 1. Pruritic papules of Fox-Fordyce disease in the axilla prior to liposuction-assisted curettage.


Treatment with oral contraceptives was started with minimal improvement. Oral antihistamines were ineffective in controlling the pruritus. Topical 0.025% tretinoin cream and clindamycin in propylene glycol solution, each used separately, did not improve her symptoms and were discontinued due to . . . [Full Text of this Article]

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.